Debt Financing Funded Health Care Startups
Across 45 debt-financing rounds in health care, the largest disclosed amount is Jubilant Pharma’s $400M (2022-07-13).
Across 45 debt-financing rounds in health care, the largest disclosed amount is Jubilant Pharma’s $400M (2022-07-13). That figure dwarfs the next-highest disclosed rounds in this table, including RefleXion Medical’s $125M (2022-07-06) and American Nitrile’s $105M (2022-03-09), while many other entries sit below $30M, with several under $10M. Date-wise, the list is back-loaded: the most recent entry is Robin Healthcare (Berkeley) on 2022-10-24, and multiple rounds cluster in October 2022 (e.g., Robin Healthcare $7M on 2022-10-24; Cooey Health $30K on 2022-10-18; SpinDiag $15M on 2022-10-17; Cellens $590K on 2022-10-14). Geographic patterns are also visible: California appears repeatedly (e.g., Robin Healthcare 2022-10-24 in Berkeley; INBRACE $45M on 2022-07-11 in Irvine; RefleXion Medical $125M on 2022-07-06 in Hayward; Honor $300M on 2021-10-05 in Concord), and Switzerland shows a tight two-company cluster on 2022-09-22 (EBAMed $100K and Terapet $100K, both Geneva).
Most recent rounds
45 shownRelated listings
Frequently asked
Which disclosed debt round is the size outlier in this health care list?
Jubilant Pharma’s $400M debt round on 2022-07-13 is the clear outlier; the next-largest disclosed amounts shown are $300M for Honor (2021-10-05) and $125M for RefleXion Medical (2022-07-06).
How concentrated are rounds in time near the top of the table?
The most recent round is Robin Healthcare on 2022-10-24. Several entries fall within October 2022 (2022-10-24 through 2022-10-11), including Cooey Health ($30K, 2022-10-18), SpinDiag ($15M, 2022-10-17), Cellens ($590K, 2022-10-14), and Micro Medical Solutions ($2M, 2022-10-14).
Are any locations or cities over-represented compared to the rest?
California recurs multiple times, spanning Berkeley (Robin Healthcare, $7M on 2022-10-24), Irvine (INBRACE, $45M on 2022-07-11), Hayward (RefleXion Medical, $125M on 2022-07-06), and Concord (Honor, $300M on 2021-10-05). Switzerland also forms a tight two-company window on 2022-09-22 in Geneva (EBAMed $100K and Terapet $100K).
Do the disclosed amounts cluster in a lower range, or are they evenly spread?
Beyond the high outliers ($400M, $300M, $125M, $105M), many disclosed rounds are comparatively modest, including multiple single-digit and low tens of millions such as Cooey Health $30K (2022-10-18), EBAMed/Terapet $100K (2022-09-22), and several $6M–$12M rounds (e.g., Lumeon $10M on 2022-01-10; MolecuLight $10M on 2022-01-04; TwelveStone $12M on 2021-10-12).
Are there any data-quality patterns in amounts that could affect analysis?
One row shows an undisclosed amount: Dawaa Dost (Jaipur) on 2022-04-05 has 'undisclosed' and therefore does not participate in comparisons like largest/smallest disclosed amounts. The smallest disclosed amount in the table is $30K for Cooey Health (2022-10-18).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.